{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:41:50Z","timestamp":1769280110044,"version":"3.49.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T00:00:00Z","timestamp":1268956800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000712","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T21:37:30Z","timestamp":1268948250000},"page":"e1000712","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":51,"title":["Tumor Growth Rate Determines the Timing of Optimal Chronomodulated Treatment Schedules"],"prefix":"10.1371","volume":"6","author":[{"given":"Samuel","family":"Bernard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branka","family":"\u010cajavec Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"L\u00e9vi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanspeter","family":"Herzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,3,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature00965","article-title":"Coordination of circadian timing in mammals.","volume":"418","author":"SM Reppert","year":"2002","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/BF01930381","article-title":"Toward a chronotherapy of neoplasia: tolerance of treatment depends upon host rhythms.","volume":"29","author":"F Halberg","year":"1973","journal-title":"Experientia"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ejca.2005.11.017","article-title":"Chronomodulated chemotherapy for colorectal cancer: failing the test of time?","volume":"42","author":"CH Takimoto","year":"2006","journal-title":"Eur J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.11040","article-title":"Cancer chronotherapy: principles, applications, and perspectives.","volume":"97","author":"MC Mormont","year":"2003","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.pharmtox.47.120505.105208","article-title":"Circadian rhythms: mechanisms and therapeutic implications.","volume":"47","author":"F L\u00e9vi","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1049\/iet-syb.2008.0104","article-title":"Chemotherapy may be delivered based on an integrated view of tumour dynamics.","volume":"3","author":"B Ribba","year":"2009","journal-title":"IET Systems Biology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(02)00961-3","article-title":"The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.","volume":"111","author":"L Fu","year":"2002","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.1086271","article-title":"Control mechanism of the circadian clock for timing of cell division in vivo.","volume":"302","author":"T Matsuo","year":"2003","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood.V77.12.2603.2603","article-title":"DNA synthesis in human bone marrow is circadian stage dependent.","volume":"77","author":"R Smaaland","year":"1991","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2184.35.s1.1.x","article-title":"Cell kinetic studies in the murine ventral tongue epithelium: thymidine metabolism studies and circadian rhythm determination.","volume":"53","author":"CS Potten","year":"2002","journal-title":"Cell Prolif"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/jnci\/90.19.1480","article-title":"Evidence for an ontogenetic basis for circadian coordination of cancer cell proliferation.","volume":"90","author":"WJ Hrushesky","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1158\/0008-5472.CAN-04-0674","article-title":"Effects of chronic jet lag on tumor progression in mice.","volume":"64","author":"E Filipski","year":"2004","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jnci\/dji083","article-title":"Effects of light and food schedules on liver and tumor molecular clocks in mice.","volume":"97","author":"E Filipski","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"R198","DOI":"10.1016\/S0960-9822(03)00124-6","article-title":"The network of time: understanding the molecular circadian system.","volume":"13","author":"T Roenneberg","year":"2003","journal-title":"Curr Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1073\/pnas.0707772105","article-title":"Molecular insights into human daily behavior.","volume":"105","author":"SA Brown","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1000193","DOI":"10.1371\/journal.pcbi.1000193","article-title":"Analysis of gene regulatory networks in the mammalian circadian rhythm.","volume":"4","author":"J Yan","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"ref17","first-page":"321","article-title":"On the existence of a G<sub>0<\/sub> phase in the cell cycle.","volume":"3","author":"FJ Burns","year":"1970","journal-title":"Cell Tissue Kinet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1073\/pnas.70.4.1263","article-title":"Do cells cycle?","volume":"70","author":"JA Smith","year":"1973","journal-title":"Proc Natl Acad Sci, USA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V51.5.941.941","article-title":"Unified hypothesis of the origin of aplastic anemia and periodic hematopoiesis.","volume":"51","author":"MC Mackey","year":"1978","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.crma.2005.10.029","article-title":"Circadian rhythm and tumour growth.","volume":"342","author":"J Clairambault","year":"2006","journal-title":"C R Acad Sci Paris, Ser I"},{"key":"ref21","first-page":"72","article-title":"Why do cells cycle with a 24 hour period?","volume":"17","author":"S Bernard","year":"2006","journal-title":"Genome Inform"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.addr.2006.09.022","article-title":"A cell cycle automaton model for probing circadian patterns of anticancer drug delivery.","volume":"59","author":"A Altinok","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1051\/mmnp\/20094308","article-title":"Comparison of Perron and Floquet eigenvalues in age structured cell division cycle models.","volume":"4","author":"J Clairambault","year":"2009","journal-title":"Math Model Nat Phenom"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000012031","article-title":"Infusions of fluorouracil and leucovorin: effects of the timing and semi-intermittency of drug delivery.","volume":"57","author":"A Falcone","year":"1999","journal-title":"Oncology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/jtbi.2000.2255","article-title":"Resonance in periodic chemotheray: A case study of acute myelogenous leukemia.","volume":"209","author":"LK Andersen","year":"2001","journal-title":"J Theor Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0959-8049(92)90463-C","article-title":"Effect of the dosing interval on myelotoxicity and survival in mice treated by cytarabine.","volume":"28A","author":"Z Agur","year":"1992","journal-title":"Eur J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1470-2045(00)00326-0","article-title":"Circadian chronotherapy for human cancers.","volume":"2","author":"F L\u00e9vi","year":"2001","journal-title":"Lancet Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.addr.2006.11.001","article-title":"Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.","volume":"59","author":"F L\u00e9vi","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1098\/rsta.2008.0114","article-title":"Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.","volume":"366","author":"F L\u00e9vi","year":"2008","journal-title":"Philos Transact A Math Phys Eng Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2006.06.1440","article-title":"Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.","volume":"24","author":"S Giacchetti","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref31","first-page":"1407","article-title":"Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.","volume":"55","author":"P Johnston","year":"1995","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.tpj.6500012","article-title":"Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy.","volume":"1","author":"S Pullarkat","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"ref33","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase 1.","volume":"6","author":"D Salonga","year":"2000","journal-title":"Clin Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0215(20001101)88:3<479::AID-IJC23>3.0.CO;2-Z","article-title":"Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage.","volume":"88","author":"D Lincoln 2nd","year":"2000","journal-title":"Int J Cancer"},{"key":"ref35","first-page":"197","article-title":"Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.","volume":"50","author":"B Harris","year":"1990","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.1998.443","article-title":"Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.","volume":"78","author":"J Mirjolet","year":"1998","journal-title":"Br J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0002-9440(10)64135-1","article-title":"Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases.","volume":"158","author":"GA Bjarnason","year":"2001","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/jtbi.1997.0613","article-title":"Resonance effect in self-renewing tissues.","volume":"192","author":"BF Dibrov","year":"1998","journal-title":"J Theor Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2008.10.024","article-title":"Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling.","volume":"36","author":"A Altinok","year":"2009","journal-title":"Eur J of Pharm Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/bjs.1800780120","article-title":"Proliferation characteristics of human colorectal carcinomas measured in vivo.","volume":"78","author":"DA Rew","year":"1991","journal-title":"Br J Surg"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1158\/1535-7163.MCT-06-0177","article-title":"Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index.","volume":"5","author":"P Wood","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1634\/theoncologist.11-10-1072","article-title":"Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer.","volume":"11","author":"D Gholam","year":"2006","journal-title":"Oncologist"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(97)03358-8","article-title":"Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy.","volume":"350","author":"F L\u00e9vi","year":"1997","journal-title":"Lancet"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T04:14:49Z","timestamp":1591157689000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000712"}},"subtitle":[],"editor":[{"given":"Christos A.","family":"Ouzounis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,3,19]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000712","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,19]]}}}